Campobasso O, Invernizzi B, Musso M, Berrino F. Survival rates of lung cancer according to histological type. Br J Cancer. 1974 Mar; 29 (3):240–246. [ PMC free article ] [ PubMed ]Campobasso, 0., Invemizzi, B.. Musso, M. et al. Survival rates of lung cancer according to ...
Small-cell lung cancer grows rapidly. The time from the development of symptoms of SCLC to diagnosis is usually 90 days or less. Small-cell lung cancer spreads quickly. From 67%-75% of people who develop small cell lung cancerwill have spread the SCLC outside of the lung to other parts ...
That’s why some 40% of lung cancers aren’t discovered until the most serious stage: IV. Also, younger people tend to live longer after their diagnosis than those who are older. Relative survival rates for non-small-cell lung cancer (NSCLC): Almost 90% of lung cancers are this type. ...
There are two major types of lung cancer: small cell lung cancer and non-small cell lung cancer. Non-small cell lung cancer (NSCLC)is the most common type and accounts for up to 85% of all lung cancer cases. It responds better to lung cancer treatment than other types. This type of ...
BACKGROUND: Small cell lung cancer (SCLC) is an extremely aggressive tumor with a poor clinical course. Although many efforts have been made to improve patients' survival rates, patients who survive longer than 2 years after chemotherapy are still very rare. We examined the baseline characteristics...
Small cell lung cancer (SCLC) patients exhibit significant heterogeneity in tumor burden, physical condition, and responses to initial treatment. This diversity in treatment responses can result in varying treatment outcomes. The primary objective of this study was to explore the patient demographics ass...
Cost effectiveness analysis of two chemotherapy regimens in a randomized multicenter trial for stade III and IV non small cell lung cancer: A. Vergnenègre, E. Pham, M. Perol, F. Bonnaud and the GFPC∗ Limoges and Lyon (France) Lung Cancer, Volume 11, Supplement 1, June 1994, Pages ...
Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors. The incidence of leptomeningeal carcinomatosis (LC) has increased in patients with metastatic non鈥搒mall-cell lung cancer (NSCLC) because of recent improv... SJ Lee,JI Lee,DH...
(P = 0.007); the median OS (overall survival) from the initiation of second-line chemotherapy in these three groups were 8.07, 10.57 and 7.27 months, respectively (P = 0.021); the rates of grades Ⅲ-Ⅳ toxicities in these three groups were 47.6%, 69.2% and 30.0%, respectively (P = ...
Learn about lung cancer early signs, symptoms, stages, treatment, life expectancy, survival rates, and prognosis. See pictures of lung cancer. Lung cancer is the leading cause of cancer deaths in the U.S.